# BPC-157 TB-500 FAQ: Evidence, Safety, Dosage & Legal Status

> BPC-157 TB-500 FAQ — direct, cited answers on the Wolverine blend's evidence, side effects, dosing context, half-life, and FDA 503A and WADA status.

Twenty-one questions on the Wolverine blend, answered directly from the published record — definition, mechanism, evidence, dosing context, safety, and regulatory status.

## Definition and naming

The questions below are answered from the published research record on BPC-157 TB-500 and from FDA primary sources. Each answer leads with the direct answer; quantitative claims cite a study in the [full reference list](/references).

---

Two peptides logged as two records on one console — BPC-157 and TB-500 each weighed against its own studies and its 503A status, the combination row left reading NO-HUMAN-DATA, with no clinic behind the panel and nothing here dispensed.